TetraLogic Pharmaceuticals Corp (TLOG)

[roctober]

"Medivir's clinical pipeline consists of four projects; remetinostat for cutaneous T-cell lymphoma (phase II), birinapant in combination with Keytruda® for solid tumors (phase I), MIV-818, a nucleotide prodrug for liver cancer that recently entered into a phase I clinical trial, and MIV-711, an osteoarthritis candidate drug with fresh and promising data from the recent phase IIa extension study."

Both Remetinostat and Birinapant projects will continue, and now play bigger roles in Medivirs pipeline.